News
-
Leyden Laboratories announced that it has raised €30 million in equity financing from the European Innovation Council (EIC) Fund and Invest-NL to support development of its PanFlu intranasal human monoclonal antibody for the prevention and… Read more . . .
-
Inhaled drug developer Avalyn Pharma has announced the appointments of Jill Denning as Senior VP, Clinical Development Operations, and Kimberley Cummings as Senior VP, Regulatory Affairs. Denning was most recently VP of Clinical Development at Kinevant… Read more . . .
-
AstraZeneca has announced that it will sell the Airsupra albuterol / budesonide MDI directly to US patients through a web site called AstraZeneca Direct starting October 1, 2025. According to the company, patients with a… Read more . . .
-
ReCode Therapeutics said that the Cystic Fibrosis Foundation will provide an additional $3 million for development of RCT2100 inhaled mRNA therapy for CF and that the company has closed a funding of more than $29… Read more . . .
-
Tonix Pharmaceuticals has announced plans for a Phase 2 trial of its TNX-2900 intranasal magnesium-potentiated oxytocin in patients with Prader-Willi syndrome (PWS). According to Tonix, the FDA has already cleared the company’s IND for a… Read more . . .
-
Inhaled drug developer MannKind Corporation has announced the appointment of Ajay Ahuja as Executive VP and Chief Medical Officer. Ahuja was most recently Development and Launch Leader at Kardigan Bio; his previous experience includes executive roles at… Read more . . .
-
Gossamer Bio, which is developing inhaled dry powder seralutinib, announced a deal with Samsara BioCapital giving the company an option to acquire Respira Therapeutics along with Respira’s RT234 vardenafil DPI. On signing, Gossamer will issue 2.5 million… Read more . . .
-
Inhaler testing specialist Copley Scientific has announced the appointment of Paul Martin as Head of Business Development. Martin, who has extensive experience in business development within the OINDP space, was most recently Associate Director of… Read more . . .
-
Blow Fill Seal specialist Ritedose, which offers CDMO services and produces its own inhalation solutions, has announced that it will spend $17 million to add 10,000 sq ft of laboratory space, tripling its current lab… Read more . . .
-
Acadia Pharmaceuticals has announced that the Phase 3 COMPASS PWS trial of ACP-101 carbetocin nasal spray in Prader-Willi syndrome patients with hyperphagia failed to meet any of its endpoints, including the primary endpoint of change… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan